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ABSTRACT
Background: Pesticide self-poisoning as a method of suicide is a major global health
problem.
Objectives: To estimate the cost and per patient cost of treating pesticide self-poisoning at
different hospital levels in a Sri Lankan district, and to examine the distribution of cost
components. Another objective was to investigate changes in total cost of treatment of
pesticide poisoning for all causes at different administrative levels in Sri Lanka in 2005 and
2015.
Methods: The economic framework was a costing analysis, adopting a government perspec-
tive. Cost data were collected prospectively over a 4-month period in 2016 for patients
admitted for pesticide self-poisoning to six hospitals in the Anuradhapura District.
Assumption-based scenario analyses were run to determine changes in total pesticide poi-
soning treatment costs.
Results: We included 67 self-poisoned patients in the study. The total cost of treatment was
US$ 5,714 at an average treatment cost of US$ 85.3 (9.7–286.6) per patient (across all hospital
levels). Hospital costs constituted 67% of the total cost for treating self-poisoning cases and
patient-specific costs accounted for 29%. Direct cost of patient hospital transfer constituted
the smallest share of costs (4%) but accounted for almost half of the total costs at primary
level. The estimated total cost of treating all causes of pesticide poisoning in Sri Lanka was US
$ 2.5 million or 0.19% of the total government health expenditure (GHE) in 2015.
Conclusion: Our findings indicate that the average per patient cost of pesticide self-poison-
ing treatment has increased while the total cost of pesticide poisoning treatment as a
percentage of the total GHE in Sri Lanka has declined over the past decade. A continuous
focus on banning the most hazardous pesticides available would likely further drive down the
cost of pesticide self-poisoning and pesticide poisoning to the government.
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Background
In 2016, the World Health Organisation (WHO) esti-
mated that 793,000 people committed suicide world-
wide, equalling an annual age-standardized suicide
rate of 10.5 per 100,000 population globally [1]. The
majority of these deaths occurred in low- and middle-
income countries in Asia, including Sri Lanka with an
age-standardized suicide rate of 17.1 per 100,000 in
2012 [2].
Pesticide self-poisoning is one of the most com-
monly used methods of suicide worldwide, and a
systematic review estimated that suicide by pesti-
cide-ingestion in 2010–2014 accounted for approxi-
mately 14% of the annual suicides [3]. The easy
accessibility to pesticides in rural farming commu-
nities and the high toxicity of pesticides sold contri-
bute towards the high burden of deaths from
pesticide self-poisonings in low- and middle-income
countries in Asia [4–7].
Sri Lanka differs from many other Asian countries,
as it has free universal health-care coverage financed
by the government. Sri Lanka has a comprehensive
network of hospitals providing both preventive and
curative health-care services to all [8,9]. The direct
and indirect cost of pesticide self-poisoning are con-
siderable and include the economic costs of emer-
gency services and intensive care, loss of income
during hospitalisation and recovery, and social stigma
to a person and family [10]. Costing studies are an
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important tool for decision-makers as they provide
information on the cost of illness, as well as yield
important management and policy information con-
cerning relevant cost-savings in the overall treatment
of pesticide self-poisoning patients. Two cost of ill-
ness studies have previously been conducted in South
Asia to determine the cost of treating pesticide
self-poisoning from a governmental perspective.
Wickramasinghe et al. [11] estimated the average
cost of treating pesticide self-poisoning at primary
and secondary hospital level in Sri Lanka to be US$
4.5 and US$ 60.1, respectively, in 2005 (adjusted for
inflation to US$ (2015)). Verma et al. [12] found that
the average cost of treating self-poisoning with orga-
nophosphate in Bangladesh was US$ 218.1, split
80/20 between patient (US$ 174.4) and government
(US$ 43.6) (adjusted for inflation).
The first aim of the study was to estimate the cost of
treating pesticide self-poisoning cases in the
Anuradhapura District, Sri Lanka, at different levels of
hospital services, and to examine the distribution of
different cost components to the total costs of treat-
ment. The hospital study was part of an existing com-
munity-based cluster randomised trial (RCT) on safe
storage of pesticides taking place in the district. The
Wickramasinghe et al. study [11] had taken place in the
same district years earlier which provided an opportu-
nity to compare changes in average per patient treat-
ment cost of pesticide self-poisoning over the past 10
years. Another objective of the study was to use the cost
estimates obtained from the present hospital study and
theWickramasinghe study to investigate changes in the
total cost of treatment of all causes of pesticide poison-
ing cases at different administrative levels (district, pro-
vincial, and national) in Sri Lanka over the past decade
(2005/2015) through scenario analyses.
Methods
Study area and frame
The study took place in the Anuradhapura District,
located in the North Central Province (NCP) of Sri
Lanka, and is part of a large community-based cluster
randomised trial investigating the effect of safe sto-
rage on the mortality of pesticide self-poisoning in Sri
Lanka [13,14].
In 2015, the district had 4,064 hospital beds divided
among 34 hospitals corresponding to 4.6 beds per
1,000 people. That year, 1,796 cases of pesticide poi-
soning (including 49 fatal cases and for all causes of
pesticide poisonings) were registered at the hospitals
in the Anuradhapura District. Registered cases of pes-
ticide poisoning at the provincial and national levels
were 2,628 and 15,778, respectively, of which 64 and
374 cases, respectively, were fatal [15].
Hospital and patient sampling
Data pertaining to the cost of treating people who inten-
tionally self-poisoned with pesticides were collected
prospectively from six different hospitals in the
Anuradhapura District in the period March to July 2016.
Cost data were collected from the Anuradhapura
Teaching Hospital (THA), Thambuttegama Base
Hospital (type B), Thalawa Divisional Hospital,
Galnewa Divisional Hospital, Eppawala Divisional
Hospital, and Rajanganaya Tract 11 Divisional
Hospital. Divisional hospitals, base hospital, and
THA are referred to as primary, secondary, and ter-
tiary levels, respectively, in the following. An over-
view of levels of health-care provided at different
types of hospitals in Sri Lanka is presented in Table 1.
In the present study, one case had been registered
as self-poisoning with the highly hazardous pesticide,
organochlorine. Poisoning with this pesticide group
is unlikely as it has been banned in Sri Lanka since
1998 [18]. Furthermore, the poison type could after-
wards not be validated in the medical records and the
RCT dataset and was therefore not included in the
final study population of 67 patients.
Costing methodology
The economic framework is a costing analysis, which
adopted a government perspective in estimating the
Table 1. Health-care levels and types of government hospitals in Sri Lanka [16,17].
Level of health-
care Characteristics Type of hospital Notes
Primary health-
care
Provides non-specialist inpatient and
outpatient care
Primary medical care units
Divisional hospital Type A, B, C
Secondary health-
care
Provides health-care in different
specialitiesa
Base hospital
– Type A
– Type B
Type B hospitals have fewer basic specialities than
type A
Tertiary health-
care
Provides specialised health-care in
four main specialities
District General hospital (DGH)
Provincial General hospital (PGH)
DGH health-care also includes some sub specialities
PGH has more facilities than DGH
Teaching hospital Provides health-care in the main sub specialities, and is
used for teaching purposes
National hospital Main hospital in Sri Lanka, also provides health-care in
many sub specialities.
aSpecialities include medicine, surgery, paediatric, obstetrics, and gynaecology.
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cost of treating pesticide self-poisoning patients. The
cost is exclusively treatment costs borne by the gov-
ernment and cost to the patient or society is therefore
not included. The costing analysis included the follow-
ing cost items: consumables, transfer, personnel, capi-
tal, and overhead. Unit costs and prices were obtained
from official statistics, the health facilities and the
Medical Supply Division of the Ministry of Health
and the Provincial Department of Health. When reli-
able data were not available, case regional estimates on
unit costs were obtained from the WHO-CHOICE
database, and through personal communication with
researchers in the field. Table 2 provides an overview
of data types and sources.
All costs in the study are expressed in 2015 US
dollars, using the gross domestic product deflator.
Furthermore, the recommended discount rate of 3%
was applied to all costs [19,20].
Costs
The costs of treating pesticide self-poisoning cases
were calculated as the sum of patient-specific treat-
ment costs by poison type and the hospital costs of
admittance, i.e. the cost per bed day by hospital level
(primary, secondary, and tertiary).
Patient-specific treatment costs by poison type
A field assistant (pharmacy graduate) was stationed at
the six hospitals at different times over the 4-month
study period. The field assistant systematically regis-
tered all unit cost inputs (consumables) administered
to the patient at the different hospitals until dis-
charge. Patient treatment costs included: medical pre-
scriptions, medical devices, and laboratory tests. Fuel
costs were used as a proxy for the cost of transferring
a patient from one hospital level to the next. Costs
were calculated as the sum of the number of units
consumed multiplied by unit cost.
Hospital costs
The average per bed day unit cost represents the
‘hotel’ components of a stay at a specific hospital
level and includes capital, overhead and personnel
costs, but excludes specific costs of the individual
patient, e.g. medication and laboratory tests. The
capital and operational costs for primary and second-
ary hospitals were calculated by collecting and sum-
ming all annual operational costs of the respective
hospitals as well as the annuitized value of capital
items, including buildings. The value of the buildings
was calculated as the construction price of the build-
ing. Annuitisation was calculated under the assump-
tion that the lifetime of buildings is 60 years [21,22].
It was not possible to collect sufficient data from
THA and a unit cost of US$ 77.65 per bed day for
tertiary hospitals in Sri Lanka was obtained from the
WHO (adjusted for inflation) [23].
Sensitivity analyses of hospital study
One-way sensitivity analyses were undertaken to assess
whether parameter uncertainties impacted on the
results of the analysis. Individual input parameters’
values were varied across a range of 1–100% while
holding all other parameters constant to assess how
these changes affected the results [19]. To investigate
discounting scenarios other than the 3% rate, sensitiv-
ity analyses were run with 0% and 6% discount rates.
Scenario analyses of changes in the total
treatment cost of pesticide poisoning in Sri Lanka
In order to estimate the total cost of treating pesticide
poisoning at the district, provincial and national level,
our cost estimates were extrapolated to all the pesticide
cases registered in Anuradhapura District, NCP and Sri
Lanka (1,796; 2,564 and 15,404, respectively), in 2015
[15]. For these scenarios, the cause of poisoning was
not available for the registered cases and the cost of
treatment therefore pertain to all causes of pesticide
poisoning cases, including occupational, accidental,
and self-poisoned cases. Our findings were extrapo-
lated to cases at different hospital levels using a ‘dis-
tribution key’ of pesticide cases by poisoning type
obtained from a large, community-based, randomised
Table 2. Input parameters collected to estimate the cost of treating pesticide self-poisoning in Anuradhapura District, Sri Lanka.
Input parameters Baseline estimate Data sources
Patient-specific cost
- Medical prescriptions, medical devices, laboratory tests Varies according to poison type and hospital level Present study
Hospital cost at primary and secondary level
- Personnel costs Varies according to type Present study
- Capital costs, incl. medical equipment and ambulances Varies according to type Present study
- Operational cost of capital cost, incl. buildings 5% of total capital cost [19]
- Overhead Varies according to type Present study
- Consumables Varies according to type Present study
- Buildings
◦ Construction price LKR 5,000/6,500 per m2 Present study
◦ Lifetime of building 60 years [20,21]
Hospital cost at tertiary level
- Cost per bed day US$ 77.65 [22]
Transfer cost (fuel cost) US$ 1.4 per litre Present study
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trial conducted in the Anuradhapura District [14] (data
not included in this paper). It was assumed that (a) all
pesticide poisoning cases received medical attention,
(b) none of the cases needed admission to intensive
care units (ICU), (c) the cost of treating an accidental
or occupational case of poisoning equalled the cost of
treating a case of pesticide self-poisoning as estimated
in this study, and (d) the number of pesticide cases
registered by the Regional Director of Health Services
Division excluded transfer cases.
In addition to the base-case scenario, several
scenarios using different cost estimates were run
to assess and compare changes in the total cost of
pesticide treatment at the district, provincial, and
national levels in the years 2005 and 2015. Cost
estimates and data obtained from Wickramasinghe
et al. were used to calculate the average per patient
cost of pesticide self-poisoning treatment in 2005
(US$ 48.2 (4.5–60.1) (adjusted for inflation to US$
(2015))) and to estimate the total cost of treating
pesticide cases in the Anuradhapura District, NCP
and Sri Lanka (1,891; 2,635, and 16,910, respec-
tively) in 2005 [11,24]. It was assumed that the
number of pesticide cases registered by the
Regional Director of Health Services Division for
2005 did not include treatment of transfer cases.
Key parameters for each scenario were:
– Scenario 1: Registered cases were grouped into
two different pesticide categories (organopho-
sphate/carbamate cases, and other pesticide
cases) using a ‘distribution key’; the cost of
transfer was excluded; and an average cost esti-
mate obtained from this study was used for each
pesticide category across all hospital levels.
– Scenario 2: Registered cases were grouped into
two different pesticide categories (organopho-
sphate/carbamate cases, and other pesticide
cases) using a ‘distribution key’; the cost of
transfer was included; and a cost estimate
obtained from this study was used for each
pesticide category by hospital level.
– Scenario 3: Registered cases were grouped into
three different pesticide categories (organopho-
sphate, carbamate, and other pesticides) using a
‘distribution key’; the cost of transfer was
included; and a cost estimate obtained from this
study was used for each pesticide category by
hospital level.
Results
Patient characteristics
The study was conducted over a 4-month period in
2016, and 67 pesticide self-poisoning patients were
registered at the six different hospitals. Almost 60%
(n = 39) of the patients were transferred to the THA,
while one patient was transferred to the District
General Hospital Chilaw (DGH Chilaw) in Puttalam
District for further treatment. All treatment costs
incurred at DGH Chilaw were excluded. Transfer and
treatment costs incurred at hospitals in the
Anuradhapura District were included in the hospital
study, including transfer costs out of the district.
Twenty-five patients were registered at the primary
hospital level, 28 patients at the secondary level, and
14 patients at the tertiary level. None of the registered
cases in the study was severe enough to require admis-
sion to ICU. There were more men than women
admitted for pesticide self-poisoning. The majority of
patients were admitted for treatment of insecticide
poisoning (72.1%), of which the most common class
of pesticides ingested was organophosphate (30.9%).
The average length of stay of hospital admittance was
26 h and 39 min for each patient (see Table 3 for
details). An overview of the different pesticides used
to self-poison identified in the study and their asso-
ciated chemical group, active compound, and toxicity
can be found in the Supplementary Section.
Total cost and cost profile
The total cost of treating the 67 patients amounted to
US$ 5,714, equalling an average cost of US$ 85.3
(9.7–286.6) per treated patient. The total cost of
patient-specific treatment amounted to US$ 1,637.6,
and the estimated cost per bed day at primary and
secondary hospital level was US$ 16.2 and US$ 67.2,
respectively. The average cost by pesticide type across
hospital levels was highest for carbamate at US$ 119.9
(5.4–619.2), followed by organophosphate at US$
107.9 (4.6–653.3). Treatment at the tertiary hospital
level accounted for the largest share of the total costs
(70.2%). The average cost was US$ 286.6 (20.7–653.3)
Table 3. Characteristics of pesticide self-poisoned patients
admitted to six hospitals in Anuradhapura District, Sri
Lanka, from 1 March to 31 July 2016.
Variable n (%)
Patients 67 (100)
Mean age (SD) 36.15 (15.6)
Gender
- Female 27 (40.3)
- Male 40 (59.7)
Poison type Chemical group
Insecticide 48 (71.6)
- Carbamate 16 (23.9)
- Organophosphate 21 (31.3)
- Other 11 (16.4)
Herbicide 19 (28.4)
Average length of stay per poison type (h)
Insecticide 31 h 38 min
- Carbamate 25 h 34 min
- Organophosphate 23 h 14 min
- Other 56 h 27 min
Herbicide 15 h 28 min
Total length of stay in average (h) 27 h 2 min
Patients transferred 40 (58.8)
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for treatment at the tertiary level, while treatment
costs were US$ 9.7 (2.7–15.5) and US$ 52.1 (7.7–
280.3) for primary and secondary level, respectively.
See Table 4 for details.
Figure 1(a) shows the distribution of the costs
among the components: hospital costs (capital costs,
overhead, personnel costs), patient-specific costs
(medical prescriptions, medical devices, laboratory
tests), and transfer costs (fuel costs). Hospital costs
constitute the largest cost component of the total cost
for treating self-poisoning cases (67%), and transfer
costs the smallest share (4%). Additionally, Figure 1
(b) shows a cost profile with a further breakdown of
cost components. The profile is based on the five
hospitals at the primary and secondary hospital levels
since it was not possible to break down tertiary cost
data. Hospital costs accounted for 61% of the total
costs, of which personnel costs constituted the largest
share of expense in the analysis, accounting for 54%
of the total costs, followed by patient-specific costs
(26%) and transfer costs (13%). A further breakdown
of cost components at primary hospital level showed
that transfer costs accounted for 47% of the total
treatment cost at this level (data not shown).
Sensitivity analyses of hospital study
The sensitivity analyses showed that the total costs
were sensitive to assumptions about personnel (sal-
aries and number of personnel), transfers (fuel prices
and number of transfers) and patient-specific costs
(medicine and test prices), especially at the primary
hospital level. A reduction of 50% in the number of
transfers from the primary hospital level to a higher
hospital level provided a 25% decrease in costs of
treatment at that level. The total cost was not sensi-
tive to changes in discount rates, lifetime of equip-
ment and buildings, construction price of buildings,
number and cost of equipment, and overhead.
Finally, a sensitivity analysis was carried out on the
cost per bed day at the tertiary level obtained from
WHO. In a scenario where changes in capital, over-
head, and/or personnel costs lead to an increase of
10% in per bed day cost, the total cost increased by
almost 5% (data not shown).
Scenario analyses on the total cost of treating
pesticide poisoning cases in Sri Lanka in 2005/2015
Extrapolating our results to the national level, the
total cost of treating pesticide poisoning cases
(including self-poisoning, accidental, and occupa-
tional) in Sri Lanka amounted to US$ 2.5 million or
0.19% of the total government health expenditure
(GHE) in Sri Lanka in 2015. The total cost of treating
pesticide poisoning cases in the NCP and
Anuradhapura District in 2015 was US$ 421,747
and US$ 295,420, respectively, equalling 0.32% and
0.22%, respectively, of the GHE in the NCP.
The results of the scenario analyses on cost and
distribution parameters are shown in Table 5. In
scenario 1, the total costs of treating all registered
pesticide poisoning cases in Sri Lanka increased by
37% between 2005 and 2015. In scenarios 2 and 3, the
total cost of treatment of pesticide poisoning cases
decreased overall with 20%. However, in all scenarios,
Table 4. Average treatment costs by poison type and hospital level for pesticide self-poisoned patients in Anuradhapura District,
Sri Lanka, from 1 March to 31 July in 2016.
Hospital level
Pesticide type Primary level (USD, 2015) Secondary level (USD, 2015) Tertiary level (USD, 2015) All hospitals levels (USD, 2015)
Insecticide 10.0 (18)a 46.2 (20) 347.8 (10) 95.50 (48)
Carbamate 11.5 (6) 27.9 (5) 341.9 (5) 119.9 (16)
Organosphosphate 9.0 (9) 59.5 (7) 353.7 (5) 107.9 (21)
Other 10.0 (3) 46.0 (8) - (0) 36.2 (11)
Herbicide 8.7 (7) 66.9 (8) 133.7 (4) 59.5 (19)
All pesticide types 9.7 (25) 52.1 (28) 286.6 (14) 85.3 (67)
aNumber of patients in parenthesis.
Figure 1. Cost profile. (a) 67 Self-poisoned patients admitted to six different hospitals in the Anuradhapura District from 1 March
to 31 July 2016. (b) 53 Self-poisoned patients admitted to five different hospitals in the Anuradhapura District (tertiary level not
included) from 1 March to 31 July 2016.
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the total cost of treatment as a percentage of the total
GHE in Sri Lanka decreased over the decade (data
not shown).
Discussion
The aim of this study was to improve and update the
cost estimates of treating pesticide self-poisoning
cases in Sri Lanka. The study included 67 patients
admitted for pesticide self-poisoning to selected hos-
pitals in the Anuradhapura District over a 4-month
study period in 2016. The total cost of pesticide
treatment was US$ 5,714, equalling an average cost
of US$ 85.3 (9.7–286.6) per patient across all types of
pesticide poisoning and hospital levels. In 2015, the
total cost of pesticide poisoning treatment to the
government was an estimated US$ 2.5 million, or
0.19% of the total GHE.
The most expensive treatment costs per patient
were at the tertiary hospital level accounting for
70.2% of the total costs. Relative to other hospitals,
tertiary hospitals have high costs because they treat
high severity cases transferred from primary and sec-
ondary facilities [25].
Our study furthermore found that 58% of the
patients admitted to primary and secondary hospitals
were transferred to a tertiary hospital, but that trans-
fer costs constituted only 4% of the total costs.
However, when breaking cost components down to
the primary hospital level, it was found that transfer
costs constituted almost half of the total treatment
cost for this level. Our sensitivity analyses showed
that the treatment cost at this level was sensitive to
changes in fuel prices and number of transfers. The
high percentage of patients being transferred from
lower level hospitals to the teaching hospital (tertiary
level) may result from a lack of appropriate
equipment, personnel capacity, and available medi-
cines [26]. If investments were made to overcome
capacity constraints at lower level hospitals, treatment
cost would become higher but sensitivity analyses
indicate that investments in these areas would only
result in a small increase in total treatment cost. In
the case of Bangladesh, Verma et al. [12] argue that
investments in peripheral hospitals could affect the
number of pesticide cases being transferred to higher
hospital levels.
The scenario analyses showed that the total cost of
pesticide poisoning treatment as a percentage of the
total GHE had decreased over the past decade. This
difference may be explained by the increasing cost of
other health-care needs, e.g. non-communicable dis-
eases, as well as changes in disease pattern overall,
including means of self-harm, types of poisons used
for self-harm, and not least the banning of the most
hazardous pesticides. Sri Lanka has a long history of
restricting access to pesticides through bans, and in
the years following the Wickramasinghe study, bans
on the most pivotal pesticides in pesticide suicides
(paraquat, dimethoate, and fenthion) were imple-
mented making them less available [27–30]. The
country then experienced a decline in pesticide sui-
cides following these bans but concurrently saw an
increase in other methods to commit suicide [28].
Furthermore, Wickramasinghe et al. [11] found that
the cost of treating cases of self-poisoning with highly
hazardous pesticides was significantly higher than the
cost of treating less hazardous pesticides poisoning
cases because they needed care in the ICU.
In the present hospital study, the average length of
stay in the hospitals was 26 h and 39 min. This is only
one-third of the length of stay estimated in the study
by Wickramasinghe et al. [11], suggesting that poi-
soning cases identified were less severe and required
Table 5. Total cost of pesticide poisoning treatment for all patients in Sri Lanka, 2005/2015.
Scenarioa Level Total cost (US$) 2005b Total cost (US$) 2015
Base-case Sri Lanka - 2,533,772
North Central Province - 421,747
Anuradhapura District - 295,420
Scenario 1c Sri Lanka 998,928 1,369,760
North Central Province 140,801 215,267
Anuradhapura District 104,886 148,165
Scenario 2d Sri Lanka 864,828 690,723
North Central Province 136,332 114,971
Anuradhapura District 97,838 80,533
Scenario 3e Sri Lanka 874,905 695,786
North Central Province 136,332 115,814
Anuradhapura District 97,838 81,124
aAll types of pesticide poisoning (self-poisoning, accidental, and occupational).
bAdjusted for inflation.
cRegistered cases were grouped into two different pesticide categories (organophosphate/carbamate cases, and other pesticide cases) using a
‘distribution key’; the cost of transfer was excluded; and an average cost estimate obtained from this study was used for each pesticide category
across all hospital levels.
dRegistered cases were grouped into two different pesticide categories (organophosphate/carbamate cases, and other pesticide cases) using a
‘distribution key’; the cost of transfer was included; and a cost estimate obtained from this study was used for each pesticide category by hospital
level.
eRegistered cases were grouped into three different pesticide categories (organophosphate, carbamate, and other pesticides) using a ‘distribution key’;
the cost of transfer was included; and a cost estimate obtained from this study was used for each pesticide category by hospital level.
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less treatment care. The present study did not identify
any patients admitted to the ICU, thereby reducing
the length of stay and, thus, the average treatment
cost in our sample. As noted above, strict enforce-
ment of bans on highly hazardous pesticides may
help to reduce the number of highly costly treatment
cases, thereby reducing government expenditures.
Extrapolating our results to the national level the
estimated total national treatment cost for pesticide
poisoning was more than US$ 2 million in 2015.
However, the costs to society exceed this as our
estimates are only from a governmental perspective.
Suicide is the second leading cause of death among
15–29-year-olds worldwide [31], resulting in huge
losses in productivity to society due to their prema-
ture deaths. To put this in perspective, Choi et al. [32]
estimated the cost of lost productivity to society from
pesticide poisoning in South Korea to be 135.9 mil-
lion, equalling almost 91% of the total cost.
Our cost estimates differed from the previous Sri
Lankan study conducted in the same district [11] due
to differences in methodology and cost components
included in the study. Our average per patient cost of
pesticide self-poisoning treatment was higher than that
calculated for the Wickramasinghe study from 2005
(US$ 85.3 vs. US$ 48.2 (adjusted for inflation)) due to
the inclusion of health-care at the tertiary level. The
inclusion of tertiary hospital level in our study also
explained the increase in the total cost of pesticide
poisoning treatment observed in scenario 1.
Differences in hospital types included in the study
meant that our average per patient cost at the secondary
level was lower than that found in the Wickramasinghe
study (base hospital (US$ 52.1) vs. general hospital (US
$ 60.1)) [11]. Differences in methodology and country
practices also hinder direct comparisons between this
and the Bangladeshi study. Our average cost estimate of
treating organophosphate poisoning at the tertiary level
was found to be higher than the Bangladeshi study (US$
353.7 vs. US$ 218.1 (adjusted for inflation)) [12].
However, in the latter study capital costs were not
included in the calculations of cost per bed day. A
further reason why the cost of treatment to the govern-
ment was higher in Sri Lanka than Bangladesh was due
to universal health coverage in Sri Lanka.
Strengths and limitations
The strength of the hospital study lies in its detailed
collection of cost and patient data. A field assistant
systematically followed and collected all cost units
administered to a patient when admitted for pesticide
poisoning at one of the hospitals being monitored.
Data were collected from three levels of health-care to
estimate the average cost of treating pesticide self-
poisoning in Sri Lanka. Furthermore, hospital data
pertaining to capital costs, personnel, overhead, and
consumables were identified, quantified and ascribed
a unit cost.
The hospital study had several limitations. The
patient-specific costs are based on a very small sample
size of 67 patients. If time and budget had allowed for it,
the data collection at each hospital would ideally have
continued until a greater sample size of cases had been
obtained to ensure a wider representation of types of
pesticides and required treatment responses.While poi-
son types identified at primary and secondary level
included carbamate insecticides, organophosphorus
insecticides, herbicides, and other insecticides, only
the three former types of pesticides were identified at
the tertiary level. In a study of longer duration, other
types of pesticides, including fungicides, may have been
identified and included in the costing analysis. Finally,
the present study did not identify any patients admitted
to ICU care. A longer study period might have resulted
in the identification of ICU cases. Another explanation
for this lack of finding is that the profile of highly
hazardous poisoning cases, and thus, patients in need
of ICU, vary across the country. It is likely that the
inclusion of more hospitals in different districts would
have identified cases admitted to ICU care. It should,
therefore, be noted that our cost estimates are conser-
vative and do not reflect the cost of ICU care. The
inclusion of ICU costs would inevitably have resulted
in higher treatment costs. It must also be noted that due
to the short study period, potential seasonal differences
in pesticide use may have influenced the types of pesti-
cides found in our survey, making our cost estimations
less robust.
Our cost estimates for hospital treatment are con-
servative. Several assumptions were made in the analy-
sis around operational costs of medical equipment,
value and lifetime of buildings, and transfer costs.
However, these data limitations were taken into account
by means of sensitivity analyses. Furthermore, it was
not possible to obtain the necessary cost data to calcu-
late a cost per bed day unit for the tertiary hospital level
in Sri Lanka; therefore, the WHO’s estimate was used.
The scenario analyses were based on several
assumptions which have affected the estimates for
total treatment cost to the Sri Lankan government.
Costs of ICU and transfer cases had to be excluded
from the scenarios due to lack of available data, mean-
ing that the models underestimated the real cost to the
government. The cause of pesticide poisoning was,
likewise, unavailable for the registered pesticide poi-
soned cases in Sri Lanka. The assumption that the cost
of treating an occupational poisoned case equalled that
of treating a self-poisoned case, however, overestimated
the real cost of treatment. Occupational exposure pri-
marily occurs by skin contact or inhalation while
spraying pesticides, while pesticide self-poisoning
usually happens through ingestion which causes more
harm to the system and is, thus, more costly to treat.
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Finally, it must be noted that we compared our
cost estimates with other studies by adjusting the
estimated costs of treatment for inflation. However,
there are limitations to this approach as health-care
charges vary between countries and over time.
Despite the limitations of the study, our estimates
can to an extent indicate which pesticide classes are
the most expensive and difficult to treat, and which
cost components make up the largest part of treat-
ment work. Costing analyses are sometimes consid-
ered of a limited value, but from a preventive
perspective, studies such as this provide valuable
information that should be taken into consideration
in policymaking, budget planning, and assessing
investment in potential cost-saving interventions.
Conclusion
The cost to the government of treating pesticide
self-poisoning at different hospital levels was esti-
mated in the present study. The total cost of treat-
ment was estimated to be US$ 5,714 with an average
treatment cost of US$ 85.3 (9.7–286.6) per patient.
The average cost of treatment was highest at the
tertiary level, and hospital costs constituted the lar-
gest share of the total cost for treating self-poisoned
patients. In the study, we demonstrated that the
average per patient cost of pesticide self-poisoning
treatment has increased over the past decade.
However, an extrapolation of our findings to pro-
vincial and national levels suggests that the total cost
of treatment of pesticide poisoning as a percentage
of the GHE has declined in Sri Lanka over the
period. This change is most likely due to national
strategies aimed at phasing out the most hazardous
and costly to treat pesticides, a shift in methods to
commit suicide, and increasing cost of other health-
care needs, e.g. non-communicable diseases. A con-
tinuous focus on banning the most hazardous
pesticides available and enforcing existing bans on
highly hazardous pesticides would likely further
drive down the cost of pesticide self-poisoning and
pesticide poisoning to the government.
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